Goldfine
Adam Goldfine, Cave Creek, AZ US
Patent application number | Description | Published |
---|---|---|
20120123357 | EYE DROPPER WITH MIRROR - A container containing a fluid for depositing the fluid drop-by-drop into a user's eye, includes a mirror element for reflecting the eye to assist in accurately dispensing the eye drops into the eye. The minor element may be hingedly attached and rotatable from a closed position to a predetermined open position. Alternatively, the minor may be detachably attached at a first position adjacent the container and relocatable to a second angularly displaced position to provide a reflection of the eye receiving the eye drops. | 05-17-2012 |
Allison B. Goldfine, Wayland, MA US
Patent application number | Description | Published |
---|---|---|
20090298796 | REDUCING RISK OF TYPE 2 DIABETES (T2D) - This invention relates to methods for reducing chronic subacute inflammatory states associated with obesity and improve glycemia, thereby preventing or delaying the development of type 2 diabetes (T2D) in obese subjects, or subjects with the metabolic syndrome, using non-acetylated forms of salicylate, e.g., salsalate or trilisate. | 12-03-2009 |
20100010074 | Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control - Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment. | 01-14-2010 |
20110021468 | TREATMENT OF CARDIOVASCULAR DISEASE WITH SALICYLATES - This invention relates to methods for the treatment of atherosclerotic cardiovascular disease using a non-acetylated forms of salicylate, e.g., salsalate and/or trilisate. | 01-27-2011 |
20120028895 | Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control - Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment. | 02-02-2012 |
20130197058 | INHIBITING STRIATED MUSCLE ACTIVATOR OF RHO (STARS) TO IMPROVE GLYCEMIC CONTROL - Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of Striated Muscle Activator of Rho Signaling (STARS) activity, and methods of identifying new compounds for use in the described methods of treatment. | 08-01-2013 |
Ira Goldfine, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20120214758 | TYROSINE KINASE RECEPTOR ANTAGONISTS AND METHODS OF TREATMENT FOR PANCREATIC CANCER - A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydrogluaiaretic acid (NDGA) and doxyrubicine. | 08-23-2012 |
Ira D. Goldfine, Belvedere, CA US
Patent application number | Description | Published |
---|---|---|
20090280112 | INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS - Disclosed herein are methods and compositions for the treatment of prostate cancer with an IGF-1 receptor kinase inhibitor. Methods are also provided for the treatment of prostate cancer by identifying a level of IGF-1 receptor expression and making a decision whether to treat with an IGF-1 receptor kinase inhibitor. | 11-12-2009 |